Covestor LTD Becton Dickinson & CO Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Covestor LTD holds 715 shares of BDX stock, worth $160,338. This represents 0.11% of its overall portfolio holdings.

Number of Shares

715

Previous 114 527.19%

Holding current value

$160,338

Previous $27,000 540.74%

% of portfolio

0.11%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$221.47 - $242.41 $133,103 - $145,688	601 Added 527.19%	715 $173,000
Q2 2024 Aug 09, 2024	BUY	$225.07 - $246.17 $225 - $246	1 Added 0.88%	114 $27,000
Q1 2024 May 10, 2024	SELL	$233.45 - $247.73 $92,446 - $98,101	-396 Reduced 77.8%	113 $28,000
Q4 2023 Feb 09, 2024	SELL	$232.24 - $267.23 $76,174 - $87,651	-328 Reduced 39.19%	509 $124,000
Q3 2023 Nov 13, 2023	BUY	$254.9 - $283.59 $169,508 - $188,587	665 Added 386.63%	837 $216,000
Q2 2023 Aug 11, 2023	BUY	$238.39 - $265.32 $9,773 - $10,878	41 Added 31.3%	172 $46,000
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $82,695 - $93,366	-360 Reduced 73.32%	131 $32,000
Q4 2022 Feb 13, 2023	SELL	$218.29 - $256.91 $3,274 - $3,853	-15 Reduced 2.96%	491 $124,000
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $4,286 - $22,195	84 Added 19.91%	506 $113,000
Q2 2022 Aug 10, 2022	SELL	$234.74 - $275.42 $91,313 - $107,138	-389 Reduced 47.97%	422 $104,000
Q1 2022 May 13, 2022	BUY	$243.64 - $270.48 $88,441 - $98,184	363 Added 81.03%	811 $216,000
Q4 2021 Feb 10, 2022	BUY	$230.08 - $250.94 $103,075 - $112,421	448 New	448 $113,000

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account